161 related articles for article (PubMed ID: 28684242)
1. [Hypofractionated stereotactic body radiation therapy for adrenal metastases].
Dupic G; Biau J; Bellière-Calandry A; Lapeyre M
Cancer Radiother; 2017 Aug; 21(5):404-410. PubMed ID: 28684242
[TBL] [Abstract][Full Text] [Related]
2. [Hypofractionated stereotactic radiotherapy of bone metastases].
Pichon B; Thillays F; Bourgier C; Mahé MA; Supiot S
Cancer Radiother; 2014; 18(4):342-9. PubMed ID: 24908177
[TBL] [Abstract][Full Text] [Related]
3. Radiation Therapy in the Management of Adrenal Metastases.
Franzese C; Stefanini S; Scorsetti M
Semin Radiat Oncol; 2023 Apr; 33(2):193-202. PubMed ID: 36990636
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Adrenal Metastases with Conventional or Hypofractionated Image-guided Radiation Therapy - Patterns and Outcomes.
Buergy D; Rabe L; Siebenlist K; Stieler F; Fleckenstein J; Giordano FA; Wenz F; Boda-Heggemann J
Anticancer Res; 2018 Aug; 38(8):4789-4796. PubMed ID: 30061250
[TBL] [Abstract][Full Text] [Related]
5. [Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?].
Royer P; Salleron J; Vogin G; Taillandier L; Clément-Duchêne C; Klein O; Faivre JC; Peiffert D; Bernier V
Cancer Radiother; 2017 Dec; 21(8):731-740. PubMed ID: 28711413
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of stereotactic body radiation therapy on adrenal gland metastases: evaluation of efficacy and impact on hormonal production.
Franzese C; Stefanini S; Massaro M; Comito T; Navarria P; Clerici E; Teriaca A; Franceschini D; Reggiori G; Tomatis S; Lania A; Scorsetti M
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3619-3625. PubMed ID: 34537907
[TBL] [Abstract][Full Text] [Related]
7. Robot-assisted Extracranial Stereotactic Radiotherapy of Adrenal Metastases in Oligometastatic Non-small Cell Lung Cancer.
Celik E; Semrau R; Baues C; Trommer-Nestler M; Baus W; Marnitz S
Anticancer Res; 2017 Sep; 37(9):5285-5291. PubMed ID: 28870966
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy for metastasis to the adrenal glands.
Shiue K; Song A; Teh BS; Ellis RJ; Yao M; Mayr NA; Huang Z; Sohn J; Machtay M; Lo SS
Expert Rev Anticancer Ther; 2012 Dec; 12(12):1613-20. PubMed ID: 23253226
[TBL] [Abstract][Full Text] [Related]
9. [Stereotactic body radiation therapy and oligometastases].
Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H
Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944
[TBL] [Abstract][Full Text] [Related]
11. [Stereotactic body radiotherapy: Passing fad or revolution?].
Vallard A; Vial N; Jmour O; Rehailia-Blanchard A; Trone JC; Sotton S; Daguenet E; Guy JB; Magné N
Bull Cancer; 2020 Feb; 107(2):244-253. PubMed ID: 31864665
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.
Kothari G; Louie AV; Pryor D; Vela I; Lo SS; Teh BS; Siva S
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S17. PubMed ID: 28917255
[TBL] [Abstract][Full Text] [Related]
13. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
Leduc C; Antoni D; Quoix É; Noël G
Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
[TBL] [Abstract][Full Text] [Related]
14. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
15. Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients.
Scorsetti M; Alongi F; Filippi AR; Pentimalli S; Navarria P; Clerici E; Castiglioni S; Tozzi A; Reggiori G; Mancosu P; Ricardi U
Acta Oncol; 2012 May; 51(5):618-23. PubMed ID: 22263925
[TBL] [Abstract][Full Text] [Related]
16. Surgical and ablative therapies for the management of adrenal 'oligometastases' - A systematic review.
Gunjur A; Duong C; Ball D; Siva S
Cancer Treat Rev; 2014 Aug; 40(7):838-46. PubMed ID: 24791623
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for treatment of adrenal metastases.
Chawla S; Chen Y; Katz AW; Muhs AG; Philip A; Okunieff P; Milano MT
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):71-5. PubMed ID: 19250766
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy for oligometastases.
Lo SS; Teh BS; Mayr NA; Olencki TE; Wang JZ; Grecula JC; Lu JJ; Timmerman RD
Discov Med; 2010 Sep; 10(52):247-54. PubMed ID: 20875346
[TBL] [Abstract][Full Text] [Related]
19. [Extracranial stereotactic radiotherapy for early-stage non-small cell lung cancer and oligometastases].
Riesterer O
Praxis (Bern 1994); 2013 Oct; 102(21):1309-16. PubMed ID: 24129299
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a volumetric modulated arc therapy treatment planning solution for kidney and adrenal stereotactic body radiation therapy.
Sonier M; Chu W; Lalani N; Erler D; Cheung P; Korol R
Med Dosim; 2016 Winter; 41(4):323-328. PubMed ID: 27745995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
